Delivery Order SPE2DB24D1205-SPE2DB25FCUTX
Award Date
3/10/25
Potential Completion Date
3/11/25
Potential Value
$3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $39,359.56 and a completion date of February 11, 2025. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $3,076.58 and a period of performance through January 23, 2024. This is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $2,576.38 and a period of performance through December 11, 2024. The contract is a delivery order under an existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $37,890.24 and a completion date of May 21, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML. The award has a ceiling value of $4,625.53 and an ultimate completion date of February 19, 2025. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The $14,403.58 firm fixed-price contract has a completion date of March 14, 2023. The award is not associated with a set-aside program. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MOUNJARO 15 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $1,360.45 and a completion date of March 5, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $1,132.44 and a completion date of January 15, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $2,176.72 and a completion date of January 24, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $1,851.28 and an ultimate completion date of July 16, 2024. The contract is a delivery order, with a firm fixed price pricing type. This award is not associated with a set-aside program. AmerisourceBergen...